AIA
BHC icon

Avalon Investment & Advisory’s Bausch Health BHC Stock Holding History

Avalon Investment & Advisory’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-40,346
Closed -$7.2M – 252
2015
Q3 		$7.2M Buy
40,346
+2,314
+6% +$540K 0.32% 109
2015
Q2 		$8.45M Buy
38,032
+758
+2% +$168K 0.36% 112
2015
Q1 		$7.4M Buy
+37,274
New +$6.61M 0.32% 111
2013
Q4 		– Sell
-75,625
Closed -$7.89M – 179
2013
Q3 		$7.89M Sell
75,625
-7,054
-9% -$687K 0.51% 84
2013
Q2 		$7.12M Buy
+82,679
New +$6.52M 0.43% 101

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Avalon Investment & Advisory's BHC Position: Q4 2015 in Review

Avalon Investment & Advisory sold out of Bausch Health (BHC) in Q4 2015, closing a stake of 40,346 shares — an estimated $7.2M sold.

Avalon Investment & Advisory first reported a position in BHC in Q2 2013 and held it in 5 quarters. The position peaked at $8.45M in Q2 2015. 451 funds tracked by Wall St. Rank hold BHC as of Q4 2015.

  • Avalon Investment & Advisory reported no remaining Bausch Health position as of Q4 2015 after selling out during the quarter.
  • Avalon Investment & Advisory sold 40,346 Bausch Health shares in Q4 2015, an estimated $7.2M.
  • Avalon Investment & Advisory first reported a position in Bausch Health in Q2 2013 and held it in 5 quarters.
  • Avalon Investment & Advisory's Bausch Health position peaked at $8.45M in Q2 2015.
  • 451 funds tracked by Wall St. Rank held Bausch Health as of Q4 2015.

Based on Avalon Investment & Advisory's 13F filing for Q4 2015, filed 16 Feb 2016.